ArticleJournal of magnetic resonance imaging : JMRI2026
Accelerating 2D Kidney Magnetic Resonance Fingerprinting Using Deep Learning Based Tissue Quantification.
Article in Journal of magnetic resonance imaging : JMRI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Accelerating 2D Kidney Magnetic Resonance Fingerprinting Using Deep Learning Based Tissue Quantification.Journal of magnetic resonance imaging : JMRI · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundMagnetic Resonance Fingerprinting (MRF) is a technique that can provide rapid quantification of multiple tissue properties. Deep learning may potentially contribute to an accelerated acquisition of MRF. PURPOSE: (1) To develop a deep learning method to accelerate the acquisition for kidney MRF; (2) to evaluate its performance in healthy subjects and patients with renal masses. STUDY TYPE: Retrospective and based on internal reference data. SUBJECTS: Development set was 36 healthy subjects and 20 patients with renal masses. The testing set: 4 healthy subjects and 16 patients. FIELD STRENGTH/SEQUENCE: 3T, Steady-State Free Precession (FISP)-based MRF. ASSESSMENT: Quantification accuracy was evaluated in healthy kidneys and renal masses using quantitative metrics including normalized root-mean-square error (NRMSE) calculated based on reference maps generated using the standard template matching approach with all acquired MRF time frames. STATISTICAL TESTS: Paired Student's t-test. p < 0.05 was considered statistically significant.
resultsAccurate quantification in both T
conclusionA deep learning-based method was developed to accelerate acquisition without compromising the accuracy of relaxation time mapping using kidney MRF. These results demonstrate reliable tissue quantification with at least a two-fold acceleration for both healthy kidneys and renal masses with various subtypes and histopathological grades. EVIDENCE LEVEL: 4. TECHNICAL EFFICACY: Stage 1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.